Starting with this issue, Inside Bioassays has changed its name to Cell-Based Assay News to more accurately reflect the scope of its coverage — which, as the new tagline suggests, is high-throughput and high-content cell-based assays for drug discovery and functional genomics.
Readers of Inside Bioassays will have already noticed that since mid-last year we had begun to focus more intently on cell-based assays, an editorial decision that was made around the time that a slew of publicly traded companies began to invest heavily in cell-based assay technology. In addition, pharma, biotech, and academia alike have shifted their focus perceptibly to cell-based assay technologies both for drug discovery and basic biological research.
Lastly, Cell-Based Assay News acknowledges the continued importance of biochemical assays in biology, and will continue to cover news in this area when applicable. However, the cellular-analysis space better fits parent publication GenomeWeb News’ continued mission to cover the emerging field of systems biology, from gene to phenotype. We hope our readers also see these developing trends, and we pledge to continue to bring you the latest news every week in cell-based assay technology.
— Ben Butkus, Cell-Based Assay News editor